Please wait a minute...
European Journal of Gynaecological Oncology  2021, Vol. 42 Issue (1): 73-80    DOI: 10.31083/j.ejgo.2021.01.2189
Original Research Previous articles | Next articles
3D image guided adaptive brachytherapy in patients with locally advanced cervical cancer: experience and clinical results from a minimum of six years of follow-up
Marit Sundset1, *(), Anne Dybdahl Wanderås2, Signe Danielsen2, 3, Mirjam Delange Alsaker2, Bjørn Hagen1, Anne Beate Langeland Marthinsen2, 3
1Department of Obstetrics and Gynecology, Section of Gynecological Oncology, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway
2Cancer Clinic, St. Olavs Hospital, Trondheim University Hospital, 7006 Trondheim, Norway
3Department of Physics, Norwegian University of Science and Technology (NTNU), 7491 Trondheim, Norway
Download:  PDF(759KB)  ( 58 ) Full text   ( 15 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
In 2005, individualized 3D image guided brachytherapy was implemented for cervical cancer patients, in accordance with the (GYN) GEC ESTRO recommendation, at St. Olav's Hospital, Trondheim, Norway. This study reports the clinical results of sixty-five consecutive patients treated from 2005 to 2010. The patients were treated with curative intent using external beam radiotherapy, brachytherapy and cisplatin. Results of this treatment are presented, including Kaplan-Meier estimates for overall survival (OS) and cancer specific survival (CSS), as well as biological effective dose normalized to equivalent 2 Gy fractions to tumor, defined as high-risk clinical target volume (CTVHR ), and to organs at risk (OARs, here bladder and rectum). Morbidity was prospectively assessed and scored in accordance with the CTCAE 3.0. 92% of the patients achieved treatment response. Local control (LC) remained in all but one patient during follow-up. Five-year OS and CSS were 71% and 80%, respectively. The mean minimum dose to CTVHR for all patients was 80.2 ± 7.3 Gy; 16% and 23% of the patients developed bladder and GI symptoms respectively, 14% of all symptoms were categorized as serious (CTCAE score ≥ 3). A dose-effect relationship was observed for adverse effects of the bladder, and the findings support the more recently recommended lower total dose limit for this OAR.
Key words:  Cervical cancer      Radiotherapy      Brachytherapy      Follow-up     
Submitted:  07 July 2020      Revised:  08 August 2020      Accepted:  31 August 2020      Published:  15 February 2021     
*Corresponding Author(s):  Marit Sundset     E-mail:  Marit.Sundset@stolav.no

Cite this article: 

Marit Sundset, Anne Dybdahl Wanderås, Signe Danielsen, Mirjam Delange Alsaker, Bjørn Hagen, Anne Beate Langeland Marthinsen. 3D image guided adaptive brachytherapy in patients with locally advanced cervical cancer: experience and clinical results from a minimum of six years of follow-up. European Journal of Gynaecological Oncology, 2021, 42(1): 73-80.

URL: 

https://ejgo.imrpress.com/EN/10.31083/j.ejgo.2021.01.2189     OR     https://ejgo.imrpress.com/EN/Y2021/V42/I1/73

[1] Hiroko Machida, Hiroshi Yoshida, Kenji Izumi, Rie Nakajima, Miwa Yasaka, Tetsuji Iida, Masae Ikeda, Masako Shida, Takeshi Hirasawa, Mikio Mikami. Surgical approach in early stage cervical cancer: the Asian view point[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 30-37.
[2] Kaori Hoshino, Yasuyuki Kinjo, Hiroshi Harada, Taeko Ueda, Yoko Aoyama, Midori Murakami, Seiji Kagami, Yusuke Matsuura, Kiyoshi Yoshino. Outcomes and complications of total laparoscopic hysterectomy after conization[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 122-128.
[3] Yu-Yi Ou, Shuang Liu, Jian-Lan Zhang, Hui-Zhi Yuan, Yu-Hua Zheng. Effects of whole-course standardized nursing and humanistic care on the sleep condition and quality of life of elderly patients undergoing hysterectomy for cervical cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 154-160.
[4] Zen Watanabe, Hideki Tokunaga, Masumi Ishibashi, Shogo Shigeta, Keita Tsuji, Tomoyuki Nagai, Masahito Tachibana, Muneaki Shimada, Nobuo Yaegashi. A modified technique of laparoscopic radical trachelectomy combined with extracorporeal cervical amputation through a mini-laparotomy[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 183-188.
[5] Rikako Soma, Tadahiro Shoji, Chie Sato, Hidetoshi Tomabechi, Takayuki Nagasawa, Masahiro Kagabu, Tsukasa Baba. Successful treatment with CPT-11 plus S-1 therapy in a patient with primary signet-ring cell carcinoma of the uterine cervix: A case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 868-872.
[6] Mei Kang, Liyang Zhu, Yichun Wang. Anatomical analysis of distant lymph node metastasis from cancer of the uterine cervix: a case report and literature review[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 884-888.
[7] Angel Yordanov, Ivan Ivanov, Tereza Dineva, Sаvelina Popovska, Milena Karcheva, Strahil Strashilov, Stoyan Kostov, Stanislav Slavchev, Assia Konsoulova, Mariela Vasileva-Slaveva. Lymphoepithelioma-like carcinoma of the uterine cervix: correlation with Epstein-Barr virus and human papillomavirus infection. A single-center experience[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 913-918.
[8] Angel Yordanov, Stanislav Slavchev, Stoyan Kostov, Strahil Strashilov, Mariela Vasileva-Slaveva, Assia Konsoulova. Synchronous Primary Carcinoma of Uterine Cervix and Endometrium - Single-center retrospective study[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 939-942.
[9] Marziyeh Najafi, Zahra Nazari, Roya Shamsi, Omid Nikpayam, Alireza Bahrami, Azita Hekmatdoost, Ehsan Hejazi. Dietary patterns and risk of cervical cancer: A case-control study[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 943-948.
[10] Qianxin Chen, Jiajia Hu, Xingwang Sun, Wenbo Long. Transcriptome sequencing reveals pathways and genes dysregulated in HPV infected cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 996-1003.
[11] Lin Wang, Sulaiya Husaiyin, Peifeng Xu, Xiaoli Wang, Lili Han, Mayinuer Niyazi. Polymorphisms of human papillomavirus type 16 E7 in Uyghur women with cervical cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 1010-1015.
[12] Lucia Taja-Chayeb, Lucely Cetina, Judith Cruz-Velazquez, Delia Perez-Montiel, Norma Moreno-Soriano, Roberto Jimenez-Lima, Raul Rivera-Marquez, Catalina Trejo-Becerril, Enrique Pérez-Cárdenas, Alma Delia Chávez-Blanco, Guadalupe Dominguez-Gomez, Alfonso Dueñas-Gonzalez. Investigation of HER-2 status, treatment response and survival analysis in cervical cancer patients[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 1031-1038.
[13] Yu Hui Lim, Sheow Lei Lim, Linda Xiao Hui Lin, Lay Tin Soh, Hoon Seng Khoo Tan, Richard Ming Chert Yeo, Timothy Yong Kuei Lim. Sequential Chemoradiation versus Radiation for the Adjuvant Treatment of Stage III Endometrioid Adenocarcinoma of the Uterus[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 705-712.
[14] Eda Kucuktulu, Ahmet Fatih Yurekli. Simultaneous Integrated Intensity Modulated Radiotherapy Boost for Gynecological Cancer when Brachytherapy is not an Option[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 720-725.
[15] Wook Youn Kim, Shin Hee Seo, Seung-Hyuk Shim, Jin Hee Park, Hyung Kyu Park, Kyeong A So, Tae Jin Kim, Sun Joo Lee. Correlation of immunohistochemistry and silver in situ hybridization for the assessment of c-MET in uterine cervical cancer patients treated with radical hysterectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 745-752.
No Suggested Reading articles found!